We are live on ! Find out more
SBRA icon

Sabra Healthcare REIT

342 hedge funds and large institutions have $3.15B invested in Sabra Healthcare REIT in 2024 Q1 according to their latest regulatory filings, with 38 funds opening new positions, 126 increasing their positions, 110 reducing their positions, and 49 closing their positions.

New
Increased
Maintained
Reduced
Closed

254% more call options, than puts

Call options by funds: $4.51M | Put options by funds: $1.27M

15% more repeat investments, than reductions

Existing positions increased: 126 | Existing positions reduced: 110

4% more capital invested

Capital invested by funds: $3.03B → $3.15B (+$117M)

0.33% more ownership

Funds ownership: 91.83%92.16% (+0.33%)

0% more funds holding in top 10

Funds holding in top 10: 33 (0)

5% less funds holding

Funds holding: 359342 (-17)

22% less first-time investments, than exits

New positions opened: 38 | Existing positions closed: 49

Holders
342
Holders Change
-17
Holders Change %
-4.74%
% of All Funds
4.93%
Holding in Top 10
3
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.04%
New
38
Increased
126
Reduced
110
Closed
49
Calls
$4.51M
Puts
$1.27M
Net Calls
+$3.24M
Net Calls Change
+$362K
Name Holding Trade Value Shares
Change
Change in
Stake
HCM
201
HGI Capital Management
New York
$373K -$121K -8,765 -26%
Bank of Nova Scotia
202
Bank of Nova Scotia
Ontario, Canada
$362K +$339K +24,513 New
II
203
Inspire Investing
Idaho
$360K -$32.5K -2,346 -9%
Federated Hermes
204
Federated Hermes
Pennsylvania
$359K -$10.8K -781 -3%
ECM
205
EMC Capital Management
Texas
$354K +$19.4K +1,400 +6%
Neuberger Berman Group
206
Neuberger Berman Group
New York
$341K -$103K -7,469 -24%
RJFSA
207
Raymond James Financial Services Advisors
Florida
$333K -$70.4K -5,085 -18%
US Bancorp
208
US Bancorp
Minnesota
$331K +$23.7K +1,713 +8%
CFGS
209
Concourse Financial Group Securities
Alabama
$323K +$41.4K +2,992 +16%
Creative Planning
210
Creative Planning
Kansas
$322K -$15.8K -1,141 -5%
CIM
211
Cambria Investment Management
California
$322K -$31.9K -2,306 -10%
HighTower Advisors
212
HighTower Advisors
Illinois
$321K +$116K +8,363 +62%
PPW
213
Pasadena Private Wealth
California
$311K -$3.96K -286 -1%
USAA
214
United Services Automobile Association
Texas
$291K
GRP
215
Global Retirement Partners
California
$287K +$12.8K +923 +5%
MLICM
216
Metropolitan Life Insurance Company (MetLife)
New York
$285K -$8.61K -622 -3%
Focus Partners Wealth
217
Focus Partners Wealth
Massachusetts
$282K +$69 +5 +0%
SAM
218
Securian Asset Management
Minnesota
$281K -$6.51K -470 -2%
AA
219
ALPS Advisors
Colorado
$278K +$4.57K +330 +2%
VPIM
220
Vanguard Personalized Indexing Management
California
$277K -$50.4K -3,643 -16%
GIM
221
Groesbeck Investment Management
New Jersey
$271K +$254K +18,338 New
DEA
222
DoubleLine ETF Adviser
Florida
$259K +$22.3K +1,609 +10%
PA
223
Parallel Advisors
California
$259K -$1.84K -133 -0.8%
ATC
224
Argent Trust Co
Tennessee
$251K
CIS
225
Custom Index Systems
New York
$250K -$296K -21,360 -56%

SBRA Hedge Fund Activity: Q1 2024 in Review

342 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in Sabra Healthcare REIT (SBRA) for Q1 2024, worth a combined $3.15B — up 3.9% from $3.03B a quarter earlier.

Sellers outnumbered buyers: 49 funds closed out of SBRA and 38 opened new positions — a net loss of 11 holders — while 110 trimmed existing stakes and 126 added.

The largest buyer was JP Morgan Chase, adding an estimated $49.3M. The largest seller was Morgan Stanley, cutting an estimated $29.1M.

  • 342 institutional investors held Sabra Healthcare REIT (SBRA) as of Q1 2024, down from 359 in Q4 2023.
  • Funds reported $3.15B of Sabra Healthcare REIT stock for Q1 2024, up 3.9% quarter-over-quarter.
  • 38 funds opened new Sabra Healthcare REIT positions in Q1 2024 and 49 closed out, a net change of -11 holders.
  • The largest Sabra Healthcare REIT buyer in Q1 2024 was JP Morgan Chase, an estimated $49.3M added.
  • The largest Sabra Healthcare REIT seller in Q1 2024 was Morgan Stanley, an estimated $29.1M sold.

Based on aggregated 13F filings for Q1 2024.